NCT07276373 2026-02-27
Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies
Corcept Therapeutics
Phase 1/2 Recruiting
Corcept Therapeutics
Hoosier Cancer Research Network
Gustave Roussy, Cancer Campus, Grand Paris
Isala
Biond Biologics
National Health Research Institutes, Taiwan